Orakl plans to launch two new commercial products, O-Predict and O-Validate, to enhance drug development.
Organizations Involved
Gustave Roussy
Founders
Fanny Jaulin, Diane-Laure Pagès, Gustave Ronteix
Company Description
Orakl Oncology is a precision oncology company that has developed an AI-powered techbio platform combining real-world patient data with biology to improve drug development processes.